Logo

LSBC Q3 Revenues Inch Over $1M Mark, Losses Narrow

Oct 22, 2003

NEW YORK, Oct. 22 (GenomeWeb News) – Large Scale Biology reported revenues of $1.2 million for the third quarter, compared to $0.7 million in the same period last year.

The Vacaville, Calif., company had a net loss of $4.3 million for the quarter, compared to $6.8 million for the third quarter of 2002.

LSBC's R&D expenses decreased to $2.8 million, from $4.5 million in the year-ago quarter.

At the end of the third quarter, the company had $11.3 million in cash and marketable securities.

Breaking News
The Scan

Call to Look Again

More than a dozen researchers penned a letter in Science saying a previous investigation into the origin of SARS-CoV-2 did not give theories equal consideration.

Not Always Trusted

In a new poll, slightly more than half of US adults have a great deal or quite a lot of trust in the Centers for Disease Control and Prevention, the Hill reports.

Identified Decades Later

A genetic genealogy approach has identified "Christy Crystal Creek," the New York Times reports.

Science Papers Report on Splicing Enhancer, Point of Care Test for Sexual Transmitted Disease

In Science this week: a novel RNA structural element that acts as a splicing enhancer, and more.